Start here if you're new
what it is
ESCO makes special-purpose hardware and software for aerospace, utilities, and testing systems.
how it gets paid
Last year Esco Technologies made $1.1B in revenue. Aerospace & Defense was the main engine at $0.45B, or 41% of sales.
why it's growing
Revenue grew 19.2% last year. Orders and backlog both reached record levels, underscoring healthy demand across aerospace, navy platforms, utilities, and test equipment.
what just happened
ESCO posted a 56.19% earnings beat, and revenue still rose 35% to $290M.
At a glance
B++ balance sheet — above average — nothing keeping you up at night
90/100 earnings predictability — you can trust these numbers
41.0x trailing p/e — you're paying up for this one
0.2% dividend yield — cash in your pocket every quarter
11.0% return on capital — nothing to write home about
xvary composite: 62/100 — average
What they do
ESCO makes special-purpose hardware and software for aerospace, utilities, and testing systems.
ESCO sells equipment that plugs into your utility grid and aircraft systems. That makes leaving painful, because you are not swapping a phone app. Aerospace & Defense is 41% of fiscal 2025 sales, Utility Solutions Group is 32%, and Test is 27%.
How they make money
$1.1B
annual revenue · their business grew +19.2% last year
Aerospace & Defense
$0.45B
Utility Solutions Group
$0.35B
Test
$0.30B
The products that matter
utility infrastructure equipment
Utility Solutions Group
core exposure inside a $1.1B company
utilities are slow-moving customers, which is good when you own the supplier. This business sits inside a company that generated $1.1B in revenue and posted 90/100 earnings predictability.
steady demand
aircraft and navy components
Aerospace & Defense
>$200M maritime orders booked early
this is the growth engine management keeps pointing to. More than $200M in maritime orders were already booked early in the fiscal year, which gives you real demand evidence, not just PowerPoint optimism.
growth engine
specialized test equipment
Test & Measurement
margin improvement matters here
this segment is smaller on this page because the data is thin, and that matters. What you do know is management expects steady growth and better profitability inside an 11.3% net margin company.
execution lever
Key numbers
41.0x
trailing p/e
You are paying 41 dollars for every dollar of trailing earnings. That is a high bar for a company with 8.5% projected sales growth.
$1.1B
annual revenue
That is the size of the business. One bad segment does not break it, but it does matter when the stock already trades rich.
20.0%
operating margin
This is the profit slice before interest and taxes. A 1-point slip is about $11M on $1.1B of sales.
90
earnings predictability
This means profits have been steady. The market pays up for that, which is why the stock can trade at 41.0x trailing earnings.
Financial health
B++
strength
- balance sheet grade B++ — above average financial health
- risk rank 3 — safer than 50% of stocks
- price stability 70 / 100
- long-term debt $166M (3% of capital)
- net profit margin 11.3% — keeps 11 cents of every dollar in revenue
- return on equity 12% — $0.12 profit for every $1 investors have put in
B++ — functional but not a standout on the balance sheet.
Total return vs. market
You invested $10,000 in ESE 3 years ago → it's now worth $23,040.
The index would have given you $13,920.
source: institutional data · total return
What just happened
beat estimates
ESCO posted a 56.19% earnings beat, and revenue still rose 35% to $290M.
Yahoo Finance shows $1.64 actual EPS versus $1.05 expected. EDGAR lists EPS at $1.11, so the beat depends on the measure, but sales growth does not.
$290M
revenue
$1.64
eps
20.0%
gross margin
earnings beat
The 56.19% surprise mattered because it showed demand stayed hot while the stock already trades at 41.0x trailing earnings.
-
orders and backlog both reached record levels, underscoring healthy demand across aerospace, navy platforms, utilities, and test equipment.
-
esco provided an upbeat outlook for fiscal 2026, driven by portfolio repositioning and improving segment profitability.
-
sales and profit growth are both projected to rise double-digits this fiscal year.aerospace and defense remains the primary growth engine, supported by higher aircraft build rates and expanding navy programs, while maritime is off to a strong start with more than $200 million in orders already booked early in the fiscal year. utility solutions and test are also expected to post steady growth, with margin improvement anticipated across all three segments.
-
strategic execution continues to reshape the company.the integration of maritime is tracking ahead of plan, while the prior divestiture of vacco has sharpened esco’s focus on higher-growth, higher-visibility end markets. although near-term headwinds persist in renewables, management expects conditions to stabilize over time.
-
shares are down roughly 5% since early october, easing valuation somewhat after a strong run earlier in 2025.even so, longer-term appreciation potential appears unattractive at current levels, despite favorable backlog trends and improving earnings visibility into 2026.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the top risk is backlog-to-revenue conversion in aerospace, navy, and utility programs.
med
aerospace and defense demand cools
ESCO's strongest growth signals are tied to aircraft build rates and government-funded programs. Those markets can stay strong for years, then remind you they are still cyclical.
at 41.0x trailing earnings, the stock does not need a collapse to get hurt. It just needs growth to look less smooth.
med
maritime integration slips
management says integration is ahead of plan. That's good. It also means the market is now expecting that progress to continue, not reverse.
if integration drags, the promised margin lift becomes a future-story stockholders keep paying for in the present.
med
renewables weakness lasts longer
management flagged near-term pressure in renewables. This page does not show the segment exposure, which is exactly why you should not dismiss it.
thin disclosure on this page means uncertainty, not safety. Any prolonged weakness would dilute the cleaner portfolio story.
med
valuation compresses before fundamentals do
sometimes a good business is just too expensive for a while. A $179 target midpoint versus a $200.41 stock price is the street saying exactly that.
even if operations stay solid, multiple compression alone can cap returns from here.
the combined risk picture is simple: ESCO looks operationally healthy, but a 41.0x multiple leaves very little room for any backlog miss, integration stumble, or slower margin improvement.
source: institutional data · regulatory filings · risk analysis
Pay attention to
earnings
the next backlog update
record backlog is the current support beam. If it keeps rising, the growth story holds together. If it flattens, the premium multiple loses cover.
metric
return on capital above 10.0%
you are already paying like this is a premium business. Watch whether returns move materially higher than 10.0%, because that is what would make the valuation easier to defend.
risk
maritime integration progress
management says integration is ahead of plan. Keep watching margins and commentary, because execution is the easiest part of the thesis to over-assume.
trend
aircraft build rates and navy spending
aerospace and defense is doing the heavy lifting. If those end markets stay healthy, ESCO gets time to grow into the stock. If not, the valuation looks early.
Analyst rankings
short-term outlook
average
momentum score 3 — the stock is acting like the broader market, not sending a loud tactical signal.
risk profile
average
stability score 3 — you are not buying a panic stock, but you are not buying a safe-haven industrial either.
chart momentum
top 20%
technical score 2 — in human-speak, analysts think the chart still looks better than most stocks even after the recent cooling.
earnings predictability
90 / 100
high predictability means management usually delivers numbers close to what investors were already expecting.
source: institutional data
Institutional activity
165 buyers vs. 183 sellers in 3q2025. total institutional holdings: 25.7M shares.
source: institutional data
Price targets
3-5 year target range
$106
$252
$200
current price
$179
target midpoint · 11% from current · 3-5yr high: $210 (+5% · 2% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive